8th Plenary Meeting EHDN 2014 Barcelona: 19-21 settembre 2014 – Report

Annarita Bentivoglio* - Marina Frontali** Si è appena concluso l’ottavo meeting plenario del Network Europeo per la Malattia di Huntington. Oltre 900 partecipanti: l’incontro più numeroso...

Fatal cellular malfunction identified in Huntington’s disease

Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities...

Roche announces details of its ‘pivotal’ huntingtin-lowering study

The GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington's disease t’s a time of huge developments in the...

New £9.1m contract with a top 10 global pharmaceutical company

Specialist medical imaging services for a Phase III Huntington’s disease clinical trial, highlighting the value of IXICO’s data science expertise in neuroscience drug development. IXICO...

Predict the onset and course of Huntington’s disease

The origin of this incurable nervous disease lies in minute fibers formed by chains of the huntingtin protein MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE IN...

Study Suggests Potential Therapy for Huntington’s Disease

A new study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that Huntington’s disease may take effect much earlier in life than...

PRIME designation granted by European Medicines Agency for RG6042 for treatment...

European Medicines Agency PRIME (PRIority MEdicines) status is granted to medicines that may offer a major therapeutic advantage over existing treatments, or benefit...

Disappointing news from LEGATO-HD trial of laquinimod in Huntington’s disease

The LEGATO-HD trial of laquinimod did not slow progression of Huntington's disease. Here's the lowdown. The LEGATO-HD trial of laquinimod to slow progression of Huntington’s...

HDBuzz Enrolls in Enroll-HD

As promised, HDBuzz's Jeff Carroll finally signed up for the Enroll-HD study. Learn more about this important global HD "observational study" here. The Enroll-HD study...

Malattia di Huntington, un’altra delusione per laquinimod

Un'altra delusione per laquinimod, probabilmente l'ultima. Il farmaco non ha raggiunto l'end point in uno studio di fase II nella malattia di Huntington. Dopo...

Active Biotech provides update on laquinimod in Huntington’s disease

PRESS RELEASE   Lund Sweden, July 31, 2018 -Active Biotech (NASDAQ OMX NORDIC: ACTI) today provided an update regarding the clinical development of laquinimod by Teva...

Researchers discover system that reduces neurodegeneration in Huntington’s disease

Mechanism that could reduce the toxic aggregation of huntingtin protein discovered / new therapies possible in the long run The neuroscientist Dr David Vilchez and...

SOM Biotech Announces Initiation of Phase 2a Clinical Trial of SOM3355...

SOM Biotech, a clinical-stage biopharmaceutical company that discovers and develops drugs for orphan indications in the Central Nervous System, has announced today the successful...

How CRISPR can be used to eradicate Huntington’s disease

NUI Galway’s Eoin Murphy was crowned the 2018 Researchfest champion for his amazing presentation on how he is using CRISPR to eradicate Huntington’s disease. Now...

Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a...

Retrotope and collaborators led by Dr. Marie-Francoise Chesselet, the Charles H. Markham Professor of Neurology, and Interim Chair of the Department of Neurology at...

First Dolly, now Piglet; a new Huntington’s disease pig knock-in model...

For the first time in HD research, an animal model has been created in pigs using 2 cutting edge DNA editing t Exciting news for...

New Therapies on the Horizon for Huntington’s Disease

Despite advances in treatment for a multitude of neurological conditions such as multiple sclerosis and Parkinson’s disease, Huntington’s disease remains incurable. This relatively rare...

New insight into Huntington’s disease may open door to drug development

Researchers have developed a new theory on Huntington’s disease which is being welcomed for showing promise to open new avenues of drug development for...

Scientists develop new approach to understand Huntington’s

Neurological diseases are typically associated with a multitude of molecular changes. But out of these thousands of changes in gene expression, which ones are...

Researchers find important new piece in the Huntington’s disease puzzle

HUNTINGTON'S DISEASE In a new study, researchers from the University of Copenhagen have discovered a hitherto unknown error in the transport of glutamine between astrocytes...

Indian Researchers Find Insulin Clue to Huntington’s Disease

A study by researchers at Department of Genetics at Delhi University South Campus has indicated that it was possible to restrict the progression of Huntington’s disease...

Nature Outlook | 31 May 2018 Huntington’s disease

There is fresh hope for treating Huntington’s disease, an inherited neurodegenerative condition that causes uncontrollable movements, emotional disturbance and the loss of mental abilities....